Onderneming Cyclacel Pharmaceuticals, Inc.
Aandelen
CYCC
US23254L8019
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,51 USD | -5,62% | -15,17% | -43,45% |
Vakgebied
Aantal werknemers: 12
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Medicines
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 01-08-97 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 01-01-02 |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 17-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 83 | 01-03-06 | |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 17-12-20 |
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 01-08-97 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 01-01-02 |
Robert Spiegel
BRD | Director/Board Member | 73 | 12-09-18 |
Samuel Barker
BRD | Director/Board Member | 81 | 11-09-14 |
Kenneth Ferguson
BRD | Director/Board Member | 68 | 14-06-22 |
Karin Walker
BRD | Director/Board Member | 60 | 09-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 119 000 | 0 | 0 | 74,05 % |
Aandeel B | 0 | 264 | 0 | 0 | |
Aandeel C | 1 | 1 318 257 | 1 224 417 ( 92,88 %) | 0 | |
Aandeel D | 0 | 335 273 | 0 | 0 |
Bedrijfsgegevens
Cyclacel Pharmaceuticals, Inc.
200 Connell Drive Suite 1500
07922, Berkeley Heights
+908 517 7330
http://www.cyclacel.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-43,45% | 1,99 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers CYCC
- Onderneming Cyclacel Pharmaceuticals, Inc.